http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Huh, Joo Young,Lee, Seulah,Ma, Eun-Bi,Eom, Hee Jeong,Baek, Jiwon,Ko, Yoon-Joo,Kim, Ki Hyun TaylorFrancis 2018 Journal of enzyme inhibition and medicinal chemist Vol.33 No.1
<P><B>Abstract</B></P><P><I>Betula platyphylla</I> var. <I>japonica</I> (Betulaceae) has been used traditionally in Asian countries for the treatment of inflammatory diseases. A recent study has reported a phenolic compound, platyphylloside from <I>B. platyphylla</I>, that shows inhibition on adipocyte differentiation and induces lipolysis in 3T3-L1 cells. Based on this finding, we conducted phytochemical analysis of the EtOH extract of the bark of <I>B. platyphylla</I> var. <I>japonica,</I> which resulted in the isolation of phenolic glycosides (<B>1</B>–<B>4</B>). Treatment of the isolated compounds (<B>1</B>–<B>4</B>) during adipocyte differentiation of 3T3-L1 mouse adipocytes resulted in dose-dependent inhibition of adipogenesis. In mature adipocytes, arylbutanoid glycosides (<B>2</B>–<B>4</B>) induced lipolysis related genes HSL and ATGL, whereas catechin glycoside (<B>1</B>) had no effect. Additionally, arylbutanoid glycosides (<B>2</B>–<B>4</B>) also induced GLUT4 and adiponectin mRNA expression, indicating improvement in insulin signaling. This suggests that the isolates from <I>B. platyphylla</I> var. <I>japonica</I> exert benefial effects in regulation of adipocyte differentiation as well as adipocyte metabolism.</P>
Lung Transplantation: a 4-year Single-centre Experience
( Jiwon Lyu ),( Seong Il Park ),( Dong Kwan Kim ),( Yong Hee Kim ),( Hyeong Ryul Kim ),( Se Hoon Choi ),( Tae Jin Yun ),( Sung Ho Jung ),( Tae Sun Shim ),( Sang Bum Hong ),( Jin Won Huh ),( Jae Young 대한결핵 및 호흡기학회 2012 대한결핵 및 호흡기학회 추계학술대회 초록집 Vol.114 No.-
Objectives: Lung transplantation is currently the ultimate treatment option for patients with end-stage lung disease refractory to medical treatment. In reviewing our 4-year experience we sought to evaluate complications and survival after sequential bilateral lung transplantation. Methods: From October, 2008 to June, 2012, we performed 18 lung transplantation procedures. Underlying lung diseases were idiopathic pulmonary fibrosis in 6 patients; toxic inhalation injury in 5; post-bone marrow transplantation bronchiolitis obliterance in 3; acute respiratory distress syndrome in 2; lymphangioleiomyomatosis in 1, and angiosarcoma in 1. Data for all patients were collected and analyzed retrospectively. Procedures were carried out using standardized protocols. Results: Thirteen patients underwent double lung and five heart-lung transplantations. Among them, 12 patients (66.7%) underwent high-emergency lung transplantation. Early complications were prolonged air leak, vocal cord palsy, critical illness polyneuropathy, necrotizing pancreatitis, and renal failure requiring dialysis. Late complications consisted of airway complications (n=6), gastro-intestinal complications (n=7), diabetes mellitus (n=2), osteopenia (n=2), and post-transplantation lymphoproliferative disorders (n=1). There was no peri-operative death. Two patients (11.1%) died from 6 and 8 months after lung transplantation, because of the infection. Conclusion: We conclude that lung transplantation is a viable option for selected patients with end-stage lung disease refractory to medical treatment.